Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mereo BioPharma Group plc ("Mereo" or "the Company") (NASDAQ:MREO). Investors who purchased Mereo securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MREO.

Investigation Details

On July 9, 2025, Mereo and its development partner Ultragenyx Pharmaceutical Inc. issued a press release "announc[ing] that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward ..

https://reports.pr-inside.com/mereo-bio ... 120803.htm
Copyright PR-Inside.com 2025